205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.40%
Negative revenue growth while AMD stands at 1.16%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-29.55%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-62.46%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-62.46%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-63.67%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-65.79%
Negative EPS growth while AMD is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-64.86%
Negative diluted EPS growth while AMD is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
2.06%
Share change of 2.06% while AMD is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
-12.19%
Reduced diluted shares while AMD is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-2.02%
Dividend reduction while AMD stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-81.83%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-145.60%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
9.31%
10Y revenue/share CAGR under 50% of AMD's 120.58%. Michael Burry would suspect a lasting competitive disadvantage.
-19.03%
Negative 5Y CAGR while AMD stands at 92.34%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
1.93%
3Y revenue/share CAGR under 50% of AMD's 99.27%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
72.96%
10Y OCF/share CAGR under 50% of AMD's 211.24%. Michael Burry would worry about a persistent underperformance in cash creation.
241.61%
Below 50% of AMD's 626.57%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
333.18%
3Y OCF/share CAGR under 50% of AMD's 716.62%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
403.33%
Below 50% of AMD's 1412.88%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
20.89%
Below 50% of AMD's 334.02%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
1743.73%
3Y net income/share CAGR above 1.5x AMD's 280.51%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
305.24%
10Y equity/share CAGR above 1.5x AMD's 160.63%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
163.29%
5Y equity/share CAGR above 1.5x AMD's 35.97%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
91.82%
3Y equity/share CAGR above 1.5x AMD's 51.13%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
5.40%
Stable or rising dividend while AMD is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
-0.94%
Negative 5Y dividend/share CAGR while AMD stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-1.13%
Negative near-term dividend growth while AMD invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-11.62%
Firm’s AR is declining while AMD shows 10.03%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-4.30%
Inventory is declining while AMD stands at 3.23%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-2.70%
Negative asset growth while AMD invests at 4.54%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.20%
Under 50% of AMD's 3.31%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-6.60%
We’re deleveraging while AMD stands at 21.50%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
1.13%
We increase R&D while AMD cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-13.22%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.